NewAmsterdam Pharma Growth Metrics (2023-2025) | NAMS

Growth Metrics Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.62M0.05M0.15M0.54M0.54M0.16M-2.05M
EBITDA Margin (QoQ) -0.17M0.06M-0.46M-0.05M0.50M0.17M-0.07M-0.06M0.12M-2.05M
EBIT Margin Growth (1y) -0.35M0.02M0.16M0.60M0.16M0.21M-1.58M
EBIT Margin (QoQ) -0.20M0.08M-0.47M0.24M0.17M0.22M-0.03M-0.20M0.21M-1.57M
EBT Margin Growth (1y) -0.62M0.05M0.15M0.54M0.54M0.16M-2.06M
EBT Margin (QoQ) -0.17M0.06M-0.46M-0.05M0.50M0.17M-0.07M-0.06M0.12M-2.06M
Enterprise Value Growth (1y) 23.90%-9.03%9.80%-14.78%-145.03%-68.03%-71.62%-66.29%
Enterprise Value (QoQ) 1.36%-8.20%22.87%7.56%-41.33%10.48%1.85%-97.33%3.08%8.57%4.90%
FCF Margin Growth (1y) -0.36M0.16M0.38M0.27M0.22M-0.94M
FCF Margin (QoQ) -0.25M0.02M0.15M0.23M-0.03M-0.09M0.10M-0.92M
Net Margin Growth (1y) -0.62M0.15M0.54M0.54M0.16M-2.06M
Net Margin (QoQ) -0.46M-0.05M0.50M0.17M-0.07M-0.06M0.12M-2.06M
Operating Margin Growth (1y) -0.35M0.02M0.16M0.60M0.16M0.21M-1.58M
Operating Margin (QoQ) -0.20M0.08M-0.47M0.24M0.17M0.22M-0.03M-0.20M0.21M-1.57M
Return on Assets Growth (1y) 23.0029.0017.00
Return on Assets (QoQ) -3.004.008.0015.002.00-7.00
Return on Capital Employed Growth (1y) 32.0027.0019.00
Return on Capital Employed (QoQ) 6.004.0013.009.002.00-5.00
Return on Equity Growth (1y) -27.002.0030.0036.0023.00
Return on Equity (QoQ) -19.00-10.00-3.005.009.0018.003.00-8.00
Return on Sales Growth (1y) -0.01M0.00M0.01M0.01M0.00M-0.02M
Return on Sales (QoQ) -0.00M-532.000.00M0.00M-665.00-606.000.00M-0.02M